[144] Arlo Technologies, Inc. SEC Filing

Rhea-AI Filing Summary

Arlo Technologies, Inc. (ARLO) filing a Form 144 notifies a proposed sale of 191,934 common shares with an aggregate market value of $3,341,570.94. The shares are scheduled for sale on 09/02/2025 on the NYSE. The reported shares were acquired as Performance Stock Units on 03/04/2024. The filer also discloses recent 10b5-1 sales by Kurtis Binder totaling 282,659 shares during June–August 2025 for aggregate gross proceeds of $4,895,199.42. The filing lists 104,370,654 shares outstanding, and the seller certifies there is no undisclosed material information.

Positive

• Transparent disclosure of the proposed sale including share count, aggregate value, and planned sale date
• Acquisition details provided (shares acquired as Performance Stock Units on 03/04/2024)
• Prior 10b5-1 sales disclosed with dates and gross proceeds, enhancing insider trading transparency

Negative

• Insider selling activity: 282,659 shares sold in June–August 2025 for $4,895,199.42 in gross proceeds
• Planned additional sale of 191,934 shares (aggregate value $3,341,570.94) scheduled for 09/02/2025

Insights

Securities Analyst

TL;DR: Routine insider notice showing modest planned sale and earlier 10b5-1 sales; primarily disclosure rather than a material event.

The Form 144 provides required notice of a proposed sale of 191,934 common shares valued at $3.34 million and confirms the shares were issued as performance stock units on 03/04/2024. It also reports three 10b5-1 executions by Kurtis Binder totaling 282,659 shares with stated gross proceeds of $4,895,199.42. Given the company's outstanding share count of 104,370,654, the proposed sale represents a small fraction of total shares outstanding, and the filing functions as compliance disclosure. No earnings, debt, or corporate-action details are included to change valuation assumptions.

Corporate Governance Expert

TL;DR: The filing documents insider-derived equity vesting and systematic 10b5-1 sales; it is governance-compliant but not transformational.

The notice documents that the securities to be sold were acquired as Performance Stock Units, and it cites reliance on Rule 10b5-1 procedures for prior transactions. The signature representation that no material nonpublic information exists is standard. The disclosure aids transparency for shareholders monitoring insider liquidity, but it does not disclose any governance changes, executive departures, or material corporate actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	191934	3341570.94	104370654	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2024	Performance Stock Units	Issuer			191934	03/04/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KURTIS BINDER 5770 Fleet Street Carlsbad CA 92008	Common	08/08/2025	113912	2113978.90
10b5-1 Sales for KURTIS BINDER 5770 Fleet Street Carlsbad CA 92008	Common	07/01/2025	92247	1583613.47
10b5-1 Sales for KURTIS BINDER 5770 Fleet Street Carlsbad CA 92008	Common	06/05/2025	76500	1179607.05

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the ARLO Form 144 propose to sell?

The filing proposes sale of 191,934 common shares with aggregate market value $3,341,570.94.

When and where is the proposed ARLO sale scheduled?

The approximate date of sale is 09/02/2025 and the securities are to be sold on the NYSE.

How were the shares to be sold acquired?

The shares were acquired as Performance Stock Units on 03/04/2024.

Has the filer sold ARLO shares recently?

Yes. The filing discloses three 10b5-1 sales by Kurtis Binder on 06/05/2025 (76,500 shares), 07/01/2025 (92,247 shares), and 08/08/2025 (113,912 shares) for total gross proceeds of $4,895,199.42.

How many ARLO shares are outstanding per the filing?

The filing reports 104,370,654 shares outstanding.